Stocks and Investing Stocks and Investing
Thu, January 9, 2025
Wed, January 8, 2025

Moderna Stock Is Volatile Amid Bird Flu Developments


Published on 2025-01-08 13:41:09 - Kiplinger
  Print publication without navigation

  • Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.

The article from Kiplinger discusses the volatile nature of Moderna's (MRNA) stock due to recent developments concerning bird flu. Moderna's stock experienced significant fluctuations after the company announced it was developing an mRNA-based vaccine for the H5N1 bird flu virus, which has been detected in U.S. dairy cows, raising concerns about potential human transmission. The stock initially surged on this news but later saw declines amid broader market concerns and uncertainties about the vaccine's development timeline and efficacy. The article highlights the speculative nature of investing in biotech stocks like Moderna, where news about potential pandemics or vaccine developments can lead to rapid stock price changes. Additionally, it notes that while Moderna has been successful with its COVID-19 vaccine, the path to market for new vaccines can be fraught with challenges, including regulatory hurdles and competition from other pharmaceutical companies.

Read the Full Kiplinger Article at:
[ https://www.kiplinger.com/investing/stocks/moderna-mrna-stock-is-volatile-amid-bird-flu-developments ]
Contributing Sources